Healthcare
Sonic Healthcare Limited(SKHHY)
Live Price
Offline$13.87
-0.43% today
1Y Change
-18.39%
Window
Jun 23, 2025 โ Jun 9, 2026
- Market Cap
- $9.86B
- Revenue Growth
- +8.0%
- EPS Growth
- 0.0%
- Dividend Yield
- 5.4%
Coverage: 242 bars ยท Jun 23, 2025 โ Jun 9, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Sonic Healthcare Limited (SKHHY) is a Healthcare stock with a market cap of $9.86B and listed on OTC. The stock last traded around $13.87 and down 18.4% across the available one-year price window (Jun 23, 2025 โ Jun 9, 2026). Baseline metrics include revenue growth of +8.0%, EPS growth of 0.0%, a dividend yield of 5.4%. What stands out right now is revenue +8.0%, EPS 0.0%, free cash flow +95.2% with operating margin 19.0% and ROIC 9.3%. The dividend matters to the case here, with a current yield around 5.4%. Valuation is more restrained than many high-expectation growth names at P/E 18.3 and price/sales 0.9. Overall, the current profile looks closer to a income-oriented value setup than a generic broad-market placeholder. Stock Foundry combines SKHHY price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Near sector median
+8.0% vs +7.6% peer median
Operating Margin
Near sector median
+19.0% vs +19.4% peer median
P/E
Below sector median
18.3 vs 36.3 peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report came in below the EPS bar
2026 was reported on Feb 18, 2026 with an EPS surprise of -1.1% and a revenue surprise of +2.9%.
The setup is mixed rather than one-directional
Revenue is +8.0% and EPS is 0.0%, while operating margin sits near 19.0%.
The next real check-in already has a date
The next earnings event is scheduled for Aug 20, 2026, which is the clearest near-term catalyst for confirming whether the current trend is holding up.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged -0.4% over the next 5 trading days and finished higher after 2 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 Feb 18, 2026 | -1.1% | +8.4% | +10.0% | -4.3% |
2025 Aug 20, 2025 | -51.3% | -13.5% | -15.6% | -21.6% |
2025 Feb 18, 2025 | -4.8% | +0.8% | +4.4% | +6.3% |
Benchmark Comparison
Normalized Performance vs SPY
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
SKHHY
โ
Normalized return
SPY
โ
S&P 500
Excess Return
โ
Relative to SPY
SKHHY Max Drawdown
-30.54%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for SKHHY and SPY.
Company Overview
Sonic Healthcare Limited
Other OTC
Sonic Healthcare Limited offers medical diagnostic services in Australia. The company provides laboratory medicine/pathology; diagnostic imaging/radiology, including magnetic resonance imaging, computed tomography (CT), ultrasound, X-ray, mammography, nuclear medicine, PET CT, interventional procedures, and bone mineral densitometry; and primary care medical services comprising general practice services, occupational health services, remote health services, community and home nursing services, primary care research programs, health assessment technologies, clinical trials, and chronic disease management programs to clinicians, hospitals, community health services, and their patients. It also offers administrative services and facilities to medical practitioners. The company operates in Australia, New Zealand, the United Kingdom, the United States, Germany, Switzerland, Belgium, and Ireland. Sonic Healthcare Limited was incorporated in 1934 and is headquartered in Sydney, Australia.
- Leadership
- James Pacey Newcombe
- IPO Date
- Oct 25, 2010
- Employees
- 42.0k
- Street Address
- Grosvenor Place
- Mailing
- Sydney, NSW, 2000
- Region
- Sydney, NSW, AU
- Reporting Currency
- USD
- Investor Line
- 61 2 9855 5444
- Last Updated
- May 4, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- 18.3
- EV/EBITDA
- 13.4
- Price/Sales
- 0.9
- Price/Book
- 1.2
Growth
- Revenue
- +8.0%
- EPS
- 0.0%
- Free Cash Flow
- +95.2%
Profitability
- Gross Margin
- 29.6%
- Operating Margin
- 19.0%
- Net Margin
- 5.2%
- ROE
- 6.4%
- ROIC
- 9.3%
Balance Sheet
- Debt/Equity
- 0.86
- Current Ratio
- 1.01
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.